GGrantIndex
← Search

IMMUNOTHERAPEUTIC TARGETING OF COLON CANCER VASCULARIZATION TO ACHIEVE LONG-TERM IMMUNITY AGAINST PRIMARY AND METASTATIC DISEASE

$530,975FY2018Defense Health AgencyDOD

Texas Tech University Health Sciences Center

Investigators

View source on USAspending →
IMMUNOTHERAPEUTIC TARGETING OF COLON CANCER VASCULARIZATION TO ACHIEVE LONG-TERM IMMUNITY AGAINST PRIMARY AND METASTATIC DISEASE · GrantIndex